Literature DB >> 16388307

Retinoic acid receptor beta2 promotes functional regeneration of sensory axons in the spinal cord.

Liang-Fong Wong1, Ping K Yip, Anna Battaglia, John Grist, Jonathan Corcoran, Malcolm Maden, Mimoun Azzouz, Susan M Kingsman, Alan J Kingsman, Nicholas D Mazarakis, Stephen B McMahon.   

Abstract

The embryonic CNS readily undergoes regeneration, unlike the adult CNS, which has limited axonal repair after injury. Here we tested the hypothesis that retinoic acid receptor beta2 (RARbeta2), critical in development for neuronal growth, may enable adult neurons to grow in an inhibitory environment. Overexpression of RARbeta2 in adult rat dorsal root ganglion cultures increased intracellular levels of cyclic AMP and stimulated neurite outgrowth. Stable RARbeta2 expression in DRG neurons in vitro and in vivo enabled their axons to regenerate across the inhibitory dorsal root entry zone and project into the gray matter of the spinal cord. The regenerated neurons enhanced second-order neuronal activity in the spinal cord, and RARbeta2-treated rats showed highly significant improvement in sensorimotor tasks. These findings show that RARbeta2 induces axonal regeneration programs within injured neurons and may thus offer new therapeutic opportunities for CNS regeneration.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16388307     DOI: 10.1038/nn1622

Source DB:  PubMed          Journal:  Nat Neurosci        ISSN: 1097-6256            Impact factor:   24.884


  48 in total

Review 1.  Molecular and Cellular Mechanisms of Axonal Regeneration After Spinal Cord Injury.

Authors:  Erna A van Niekerk; Mark H Tuszynski; Paul Lu; Jennifer N Dulin
Journal:  Mol Cell Proteomics       Date:  2015-12-22       Impact factor: 5.911

Review 2.  Molecular Signaling Mechanisms of Natural and Synthetic Retinoids for Inhibition of Pathogenesis in Alzheimer's Disease.

Authors:  Mrinmay Chakrabarti; Alexander J McDonald; J Will Reed; Melissa A Moss; Bhaskar C Das; Swapan K Ray
Journal:  J Alzheimers Dis       Date:  2016       Impact factor: 4.472

3.  Comparison of AAV serotypes for gene delivery to dorsal root ganglion neurons.

Authors:  Matthew R J Mason; Erich M E Ehlert; Ruben Eggers; Chris W Pool; Stephan Hermening; Angelina Huseinovic; Eric Timmermans; Bas Blits; Joost Verhaagen
Journal:  Mol Ther       Date:  2010-02-23       Impact factor: 11.454

Review 4.  Gene therapy approaches to enhancing plasticity and regeneration after spinal cord injury.

Authors:  Steffen Franz; Norbert Weidner; Armin Blesch
Journal:  Exp Neurol       Date:  2011-01-31       Impact factor: 5.330

5.  Persistent restoration of sensory function by immediate or delayed systemic artemin after dorsal root injury.

Authors:  Ruizhong Wang; Tamara King; Michael H Ossipov; Anthony J Rossomando; Todd W Vanderah; Pamela Harvey; Peter Cariani; Eric Frank; Dinah W Y Sah; Frank Porreca
Journal:  Nat Neurosci       Date:  2008-03-23       Impact factor: 24.884

Review 6.  Kidney regeneration: common themes from the embryo to the adult.

Authors:  M Cecilia Cirio; Eric D de Groh; Mark P de Caestecker; Alan J Davidson; Neil A Hukriede
Journal:  Pediatr Nephrol       Date:  2013-09-05       Impact factor: 3.714

7.  Retinoid signaling alterations in amyotrophic lateral sclerosis.

Authors:  Christi L Kolarcik; Robert Bowser
Journal:  Am J Neurodegener Dis       Date:  2012-07-23

8.  FARP1 promotes the dendritic growth of spinal motor neuron subtypes through transmembrane Semaphorin6A and PlexinA4 signaling.

Authors:  BinQuan Zhuang; YouRong Sophie Su; Shanthini Sockanathan
Journal:  Neuron       Date:  2009-02-12       Impact factor: 17.173

9.  A retinoic acid receptor beta agonist (CD2019) overcomes inhibition of axonal outgrowth via phosphoinositide 3-kinase signalling in the injured adult spinal cord.

Authors:  Marta Agudo; Ping Yip; Meirion Davies; Elizabeth Bradbury; Patrick Doherty; Stephen McMahon; Malcolm Maden; Jonathan P T Corcoran
Journal:  Neurobiol Dis       Date:  2009-10-02       Impact factor: 5.996

Review 10.  Towards retinoid therapy for Alzheimer's disease.

Authors:  K Shudo; H Fukasawa; M Nakagomi; N Yamagata
Journal:  Curr Alzheimer Res       Date:  2009-06       Impact factor: 3.498

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.